biocon: Biocon acquires Eywa Pharma’s US-based plant for $7.7 million
Biotechnology main Biocon on Saturday stated its unit has acquired Eywa Pharma Inc's oral strong dosage manufacturing facility within the ...
Biotechnology main Biocon on Saturday stated its unit has acquired Eywa Pharma Inc's oral strong dosage manufacturing facility within the ...
on Thursday mentioned its wholly-owned arm, CuraTeQ Biologics, plans to speculate round Rs 300 crore on capability growth of biologics ...
Tadhg Ó Laoghaire, a researcher in financial ethics on the College of Gothenburg, Sweden, echoes Gillard: “They do not have ...
Copyright © 2022 Asia Today.